-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly: The base will focus on developing oral GLP-1 drug ofoglitide.

智通財經·12/09/2025 20:41:33
語音播報
Eli Lilly: The base will focus on developing oral GLP-1 drug ofoglitide.